Results 241 to 250 of about 5,486,230 (294)
A Novel Approach to Reducing Chemoresistance in Advanced Ovarian Cancer: The Effect of Itraconazole-A Single-Institution Randomized Placebo-Controlled Trial. [PDF]
Curr OncolBesheir AES +3 more
europepmc +1 more source
Multimodal Prehabilitation in Indian Women with Advanced Ovarian Cancer: Enhancing Nutritional, Psychological, and Surgical Recovery. [PDF]
Asian Pac J Cancer PrevRajan S +10 more
europepmc +1 more source
Correction: Participants' perspectives of the advanced ovarian cancer biomarker study VALTIVE1: a qualitative study. [PDF]
BMJ Openeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Top Advances of the Year: Ovarian Cancer
Obstetrical & Gynecological Survey, 2023(Abstracted from Cancer 2024;130:837–845 Although novel systemic therapies have prolonged survival in ovarian cancer, it remains the fifth leading cause of cancer-related death in women. In 2022, data showing an overall survival (OS) benefit from poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) were published after a 7-year follow-up ...
Melissa A. Lumish +2 more
openaire +2 more sources
Current Treatment Options in Oncology, 2000
State-of-the-art treatment for advanced ovarian cancer requires a multimodality approach. Aggressive surgical debulking with the goal of optimal cytoreduction is the initial step. After primary cytoreductive surgery, standard treatment for patients with stage III and IV disease is systemic combination chemotherapy consisting of six cycles of paclitaxel
D S, Chi, P, Sabbatini
openaire +2 more sources
State-of-the-art treatment for advanced ovarian cancer requires a multimodality approach. Aggressive surgical debulking with the goal of optimal cytoreduction is the initial step. After primary cytoreductive surgery, standard treatment for patients with stage III and IV disease is systemic combination chemotherapy consisting of six cycles of paclitaxel
D S, Chi, P, Sabbatini
openaire +2 more sources
Chemotherapy in advanced ovarian cancer
Journal of Cancer Research and Clinical Oncology, 1984The chemotherapy of advanced ovarian cancer is reviewed. Treatment with single agents results in low remission rates and few complete remissions. The results have been improved with modern combination chemotherapy, which includes cisplatin, although a longer follow up is needed for definite conclusions to be made concerning survival.
C J, Rodenburg, F J, Cleton
openaire +2 more sources
Advances in ovarian cancer chemotherapy
Current Opinion in Oncology, 2000Traditionally, surgery and radiation represented the pillars of cancer therapy. In contrast to the European approach, in the United States chemotherapy for ovarian cancer has replaced radiation for a long time. Nevertheless, with the aim being cure of the patient, both approaches result in a sometimes severely diminished quality of life for the woman ...
G, Deppe, P, Baumann
openaire +2 more sources
Ovarian Cancer: Advances in Management
Surgical Clinics of North America, 1991Substantial progress has been made in understanding the biologic behavior of ovarian cancer and in assessing disease states and response to therapy with transvaginal sonography, CT scan, and tumor markers such as CA-125. There is no longer controversy regarding the importance and feasibility of adequate surgical staging, the need for cytoreduction, and
G, Deppe, V K, Malviya
openaire +2 more sources
Chemotherapy for advanced ovarian cancer
American Journal of Obstetrics and Gynecology, 1966Abstract Two hundred and thirteen patients with advanced cancer of the ovary, of the three most common cell types, were studied for the benefits of phenylalanine mustard. The agent was observed to produce some antitumor effect in approximately half of the group.
F, Rutledge, B C, Burns
openaire +2 more sources
When advanced ovarian cancer is not ovarian cancer.
Journal of Clinical Oncology, 2017e17066 Background:Tissue diagnosis of advanced ovarian cancer (OC) is not universally obtained prior to up-front surgery. This study sought to investigate non-OC cases discovered in the systemic laparoscopic (LSC) workup of presumed advanced OC. Methods: A prospective cohort of presumed advanced OC patients (based on elevated CA125 and/or imaging ...
Robert Dood +4 more
openaire +1 more source